Loading…
for educational and safety purposes
Cariprazine and Aripiprazole both come up in the same conversations. Cariprazine: Cariprazine, sold as Vraylar (and Reagila in Europe), is a third-generation antipsychotic. Aripiprazole: Aripiprazole is a second-generation (atypical) antipsychotic used in schizophrenia, bipolar disorder and as an adjunct in major depression.
Cariprazine, sold as Vraylar (and Reagila in Europe), is a third-generation antipsychotic. Rather than simply blocking dopamine, it is a dopamine D3-preferring D2/D3 receptor partial agonist, meaning it partly activates those receptors and buffers dopamine signaling up or down toward a middle setpoint; it is also a 5-HT1A partial agonist and a 5-HT2B antagonist. It is used for schizophrenia and for bipolar disorder, including bipolar depression, and its standout feature is an unusually high affinity for the D3 receptor that is thought to help the negative and cognitive symptoms ordinary antipsychotics tend to leave untouched.
Aripiprazole is a second-generation (atypical) antipsychotic used in schizophrenia, bipolar disorder and as an adjunct in major depression. Rather than fully blocking dopamine D2 receptors like older agents, it acts as a high-affinity partial agonist, combined with partial agonism at serotonin 5-HT1A and antagonism at 5-HT2A receptors, so that it behaves as a dopamine system stabilizer that dampens signaling where dopamine is excessive and supports it where dopamine is deficient. This mechanism gives it antipsychotic efficacy comparable to other agents with relatively little sedation, weight gain, movement disorder or prolactin elevation, and it is also formulated as a long-acting monthly injection to support adherence. The same partial-agonist pharmacology, however, can occasionally provoke impulse-control problems such as pathological gambling, an effect it shares with dopamine agonists.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
Partial agonist
modulates
Partial agonist (high affinity, D3-preferring)
modulates
Partial agonist
activates
Antagonist
antagonist
antagonist
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.
easiest to source: Aripiprazole is currently listed by more trusted vendors (2), so it's the simpler one to get hold of. for effects and safety, read each full entry; this is educational, not medical advice.